Lataa...
Production of the Receptor-binding Domain of the Viral Spike Proteins from 2003 and 2019 SARS CoVs and the Four Common Human Coronaviruses for Serologic Assays and Inhibitor Screening
The recombinant receptor-binding domain (RBD) of the viral spike protein from SARS-CoV-1 and 2 are reliable antigens for detecting viral-specific antibodies in humans. We and others have shown that the levels of RBD-binding antibodies and SARS-CoV-2 neutralizing antibodies in patients are correlated...
Tallennettuna:
| Julkaisussa: | Bio Protoc |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Bio-Protocol
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8187116/ https://ncbi.nlm.nih.gov/pubmed/34150933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21769/BioProtoc.4026 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|